✦ LIBER ✦

Prolactin response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease

✍ Scribed by Sandeep Kumar; Robert E. Mansel; Leslie E. Hughes; J. Stuart Woodhead; Catherine A. Edwards; Maurice F. Scanlon; Robert G. Newcombe

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 459 KB
Volume: 53
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19840315)53:6<1311::aid-cncr2820530615>3.0.co;2-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thyroid hormones in benign breast diseas

Thyroid hormones in benign breast disease normalization of exaggerated prolactin responsiveness to thyrotropin-releasing hormone

✍ Friedolf Peters; C. Renate Pickardt; Meinert Breckwoldt 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 2 views

To investigate the exaggerated prolactin (PRL) responsiveness to thyrotropin-releasing hormone (TRH) in patients with benign breast disease (BBD), 18 patients and 13 healthy controls underwent an 8-week-long thyroid hormone treatment. The clinical effect of thyroid hormones on cyclical mastodynia an

Plasma prolactin responses to thyrotropi

Plasma prolactin responses to thyrotropin-releasing hormone in patients with breast cancer

✍ Shozo Ohgo; Yuzuru Kato; Kazuo Chihara; Hiroo Imura 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 1 views

Release of prolactin, thyrotropin, and g

Release of prolactin, thyrotropin, and growth hormone in women with cyclical mastalgia and fibrocystic disease of the breast

✍ Steen Watt-Boolsen; Peter Claes Eskildsen; Hanne Blæhr 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 1 views